Christopher Senner

Christopher Senner

Director of Finance/CFO at EXELIXIS, INC.

Net worth: 18 M $ as of 2024-03-30

56 year
Health Technology
Consumer Services

Profile

Currently, Christopher J. Senner occupies the position of Chief Financial Officer & Executive Vice President of Exelixis, Inc. Mr. Senner is also on the board of Cortexyme, Inc. He previously occupied the position of Vice President-Finance at Gilead Sciences, Inc. and Chief Financial Officer of Wyeth Pharmaceuticals LLC. Mr. Senner received an undergraduate degree from Bentley University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-22 754,713 ( 0.25% ) 18 M $ 2024-03-30
2023-05-23 0 ( -.--% ) - $ 2024-03-30

Christopher Senner active positions

CompaniesPositionStart
EXELIXIS, INC. Director of Finance/CFO 2015-07-14
QUINCE THERAPEUTICS, INC. Director/Board Member 2019-02-28
All active positions of Christopher Senner

Former positions of Christopher Senner

CompaniesPositionEnd
GILEAD SCIENCES, INC. Corporate Officer/Principal 2015-06-30
Director of Finance/CFO 2009-10-31
Director of Finance/CFO -
See the detail of Christopher Senner's experience

Training of Christopher Senner

Bentley University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Senner's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
GILEAD SCIENCES, INC.

Health Technology

EXELIXIS, INC.

Health Technology

QUINCE THERAPEUTICS, INC.

Health Technology

Private companies2

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Christopher Senner